DENTSPLY SIRONA Inc. (NASDAQ: XRAY), spotted trading -2.96% off 52-week high price. On the other end, the stock has been noted 69.88% away from the low price over the last 52-weeks. The stock changed -0.28% to recent value of $57.64. The stock transacted 2162179 shares during most recent day however it has an average volume of 1637.3K shares. The company has 231.05M of outstanding shares and 231.05M shares were floated in the market.

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), the Dental Solutions Company, revealed the appointment of Jorge M. Gomez as Chief Financial Officer.

Jorge M. Gomez served as Chief Financial Officer of Cardinal Health since January 2018, where he was responsible for financial activities across the enterprise, including financial strategy, capital deployment, treasury, investor relations, tax, accounting and external reporting.  Prior to that, Jorge was Chief Financial Officer of the Medical and Pharmaceutical segments, and Treasurer and Corporate Controller at Cardinal Health.  Before joining Cardinal Health, Jorge held multiple executive and leadership roles at General Motors and the Smurfit-Kappa Group.

Don Casey, Dentsply Sirona’s CEO said “On behalf of the entire management team, I would like to extend a warm welcome to Jorge Gomez.  He is a talented global executive with an in-depth knowledge of the healthcare market, who brings the right mix of skills and experience, and a solid track record of successfully managing global finance operations,”. “In addition, Jorge has a strong business sense and the ability to collaboratively lead an organization to drive increased shareholder value. I would also like to thank Nick Alexos for his efforts and dedication to Dentsply Sirona, and his leadership during the CFO transition,” continued Mr. Casey.

Its earnings per share (EPS) expected to touch remained 32.10% for this year while earning per share for the next 5-years is expected to reach at 9.18%. XRAY has a gross margin of 51.60% and an operating margin of -24.60% while its profit margin remained -26.50% for the last 12 months.

According to the most recent quarter its current ratio was 2.1 that represents company’s ability to meet its current financial obligations. The price moved ahead of 0.22% from the mean of 20 days, 4.27% from mean of 50 days SMA and performed 28.95% from mean of 200 days price. Company’s performance for the week was -1.23%, 3.61% for month and YTD performance remained 54.90%.